Nintx and Centroflora partner to harness the power of the Brazilian biodiversity to modulate the human microbiome

The partnership will build a research laboratory, headed by Prof. Katia Sivieri, to house Nintx’s proprietary xGIbiomics® technology

Nintx and Grupo Centroflora partner to harness the power of the Brazilian biodiversity to modulate the human microbiome. The partnership will build a research laboratory, headed by Prof. Katia Sivieri, PhD, to house Nintx’s proprietary xGIbiomics® technology. “For over 60 years, the Centroflora Group has been a producer of sustainable botanical extracts, essential oils, and isolated natural products for the pharmaceutical industry. Through the partnership with Nintx, Centroflora will gain access to the xGIbiomics® technology and scientific knowledge on how natural products can positively impact the human microbiome, expanding our company’s business”, said Peter Andersen, CEO, Centroflora. “We view the partnership with Centroflora as crucial in our strategy to develop multi-target therapies, as it provides not only the foundation to jumpstart Nintx’s human microbiome research laboratory, but also have quick access to plant-based ingredients produced with the utmost quality and scalability”, stated Dr. Miller Nunes de Freitas. Phd, CEO, Nintx. “We are also very honored to have Prof. Katia Sivieri onboard of Nintx as the Head of our research lab.”

To have access to the full content, check us out on LinkedIn.

https://www.linkedin.com/posts/nintx_press-release-december-14th-2021-activity-6876542770484453377-K9L-/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAAUL6oB6dOVqNQ7Ria1q2TMTlnb4Jf7Jwk